Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity

Autor: David R. Hinton, Shoba Amarnath, Takeshi Mizutani, Bradley D. Gelfand, Ana Bastos-Carvalho, Benjamin J. Fowler, Hitesh K. Agarwal, Valeria Tarallo, Charles B. Wright, Reo Yasuma, Shengjian Li, Marta Radwan, Nagaraj Kerur, Paul Kubes, Tetsuhiro Yasuma, Younghee Kim, Keykavous Parang, Keir Pittman, Yoshio Hirano, Jayakrishna Ambati, Daniel H. Fowler, Mark T. Young
Rok vydání: 2014
Předmět:
Zdroj: Science. 346:1000-1003
ISSN: 1095-9203
0036-8075
Popis: Nucleoside reverse transcriptase inhibitors (NRTIs) are mainstay therapeutics for HIV that block retrovirus replication. Alu (an endogenous retroelement that also requires reverse transcriptase for its life cycle)–derived RNAs activate P2X7 and the NLRP3 inflammasome to cause cell death of the retinal pigment epithelium in geographic atrophy, a type of age-related macular degeneration. We found that NRTIs inhibit P2X7-mediated NLRP3 inflammasome activation independent of reverse transcriptase inhibition. Multiple approved and clinically relevant NRTIs prevented caspase-1 activation, the effector of the NLRP3 inflammasome, induced by Alu RNA. NRTIs were efficacious in mouse models of geographic atrophy, choroidal neovascularization, graft-versus-host disease, and sterile liver inflammation. Our findings suggest that NRTIs are ripe for drug repurposing in P2X7-driven diseases.
Databáze: OpenAIRE